LORLATINIB Pharmacologic Class Indexing

Class set ID
775ff3d6-7a82-4a09-89c2-cb37b00a5db3
Version
2
Effective date
20210806
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use LORBRENA safely and effectively. See full prescribing information for LORBRENA. LORBRENA ® (lorlatinib) tablets, for oral use Initial U.S. Approval: 2018U.S. Pharmaceuticals | Pharmacia & Upjohn Company LLC | Viatris Pharmaceuticals LLC | Pfizer Manufacturing Deutschland GmbH | Pfizer Ireland Pharmaceuticals Unlimited Company202602133
These highlights do not include all the information needed to use LORBRENA safely and effectively. See full prescribing information for LORBRENA. LORBRENA ® (lorlatinib) tablets, for oral use Initial U.S. Approval: 2018Pfizer Laboratories Div Pfizer Inc | Pharmacia & Upjohn Company LLC | Pfizer Manufacturing Deutschland GmbH | Pfizer Ireland Pharmaceuticals Unlimited Company2026020912